News Headlines Article

Pricey generic drugs to get competition from Imprimis
Los Angeles Times

Turing Pharmaceuticals sparked nationwide outrage and government investigations by raising the cost of Daraprim, a drug for treating AIDS and cancer, from $13.50 a capsule to $750 last month.

This week, the biomedical company Imprimis Pharmaceuticals of San Diego introduced a competitor to the medication — for $1 a capsule.

Imprimis plans to take the same strategy to undercut other generic drugs sold at far more than their manufacturing cost.